Abionyx Pharma SA
LSE:0RAG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abionyx Pharma SA
LSE:0RAG
|
FR |
|
M
|
MBB SE
XBER:MBB
|
DE |
|
CTS Corp
F:XT1
|
US |
|
B
|
BYD Co Ltd
XMUN:BY6
|
CN |
|
R
|
Reckitt Benckiser Group PLC
DUS:3RB
|
UK |
|
United Labels AG
F:ULC
|
DE |
|
U
|
United Labels AG
DUS:ULC
|
DE |
Wall St Price Targets
0RAG Price Targets Summary
Abionyx Pharma SA
According to Wall Street analysts, the average 1-year price target for 0RAG is 10.7 EUR with a low forecast of 10.17 EUR and a high forecast of 11.46 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RAG's stock price target?
Price Target
10.7
EUR
According to Wall Street analysts, the average 1-year price target for 0RAG is 10.7 EUR with a low forecast of 10.17 EUR and a high forecast of 11.46 EUR.
What is the Revenue forecast for Abionyx Pharma SA?
Projected CAGR
112%
The compound annual growth rate for Revenue over the next 3 years is 112%.
What is the Gross Profit forecast for Abionyx Pharma SA?
Projected CAGR
24%
The compound annual growth rate for Gross Profit over the next 2 years is 24%.
